The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Milestone Pharmaceuticals Inc(NASDAQ:MIST) 
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the Uni...
Website: http://www.milestonepharma.com
Full Time Employees: 28
CEO: Joseph G. Oliveto
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Milestone Pharmaceuticals Days Payable Outstanding ttm (DPO)
Milestone Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Milestone Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Milestone Pharmaceuticals Op Cashflow Per Share ttm
Milestone Pharmaceuticals Free Cashflow Per Share ttm
Milestone Pharmaceuticals Cash Per Share ttm
Milestone Pharmaceuticals P/S ratio ttm
Milestone Pharmaceuticals (GAAP) P/E ratio ttm
Milestone Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.